Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1997 | 1 |
2001 | 1 |
2002 | 1 |
2004 | 1 |
2005 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein.
J Virol. 2002 Aug;76(15):7760-76. doi: 10.1128/jvi.76.15.7760-7776.2002.
J Virol. 2002.
PMID: 12097589
Free PMC article.
Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex.
Fouts TR, Binley JM, Trkola A, Robinson JE, Moore JP.
Fouts TR, et al.
J Virol. 1997 Apr;71(4):2779-85. doi: 10.1128/JVI.71.4.2779-2785.1997.
J Virol. 1997.
PMID: 9060632
Free PMC article.
Item in Clipboard
The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4.
Pugach P, Kuhmann SE, Taylor J, Marozsan AJ, Snyder A, Ketas T, Wolinsky SM, Korber BT, Moore JP.
Pugach P, et al.
Virology. 2004 Mar 30;321(1):8-22. doi: 10.1016/j.virol.2003.12.012.
Virology. 2004.
PMID: 15033560
Free article.
Item in Clipboard
The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles.
Herrera C, Klasse PJ, Michael E, Kake S, Barnes K, Kibler CW, Campbell-Gardener L, Si Z, Sodroski J, Moore JP, Beddows S.
Herrera C, et al.
Virology. 2005 Jul 20;338(1):154-72. doi: 10.1016/j.virol.2005.05.002.
Virology. 2005.
PMID: 15932765
Free article.
Item in Clipboard
Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5.
Parker CE, Deterding LJ, Hager-Braun C, Binley JM, Schülke N, Katinger H, Moore JP, Tomer KB.
Parker CE, et al.
J Virol. 2001 Nov;75(22):10906-11. doi: 10.1128/JVI.75.22.10906-10911.2001.
J Virol. 2001.
PMID: 11602730
Free PMC article.
Item in Clipboard
Cite
Cite